Article Overview

This article explains how a laboratory’s next-generation sequencing panel may be approached when the testing is performed as one procedure on one specimen but the panel spans multiple CPT molecular pathology code categories. It is aimed at coders, billing staff, and laboratory compliance teams who need to understand the general framework for identifying whether the work falls within Tier 1, Tier 2, or unlisted molecular pathology reporting. The discussion also addresses how the article treats panel components that do not have a specific code and the general handling of unlisted reporting in that context.